Personal information

Other IDs

Loop profile: 866403

Countries

United States

Activities

Collapse all

Employment (1)

MetroWest Medical Center Framingham Union Hospital/Tufts University School of Medicine: Framingham, MA, US

2019 to present | Resident (Medicine)
Employment
Source: Self-asserted source
Robin Park

Education and qualifications (2)

Korea University: Seongbuk-gu, Seoul, KR

2014 to 2018 | MD
Education
Source: Self-asserted source
Robin Park

McGill University Faculty of Science: Montreal, QC, CA

2008 to 2012 | BSc (Interdepartmental Honours Immunology)
Education
Source: Self-asserted source
Robin Park

Works (34)

Advanced Human Papillomavirus–Negative Head and Neck Squamous Cell Carcinoma: Unmet Need and Emerging Therapies

Molecular Cancer Therapeutics
2024-12-03 | Journal article
DOI: 10.1158/1535-7163.MCT-24-0281
Contributors: Robin Park; Christine H. Chung
Source: check_circle
Crossref

Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Oral Oncology
2024-07 | Journal article
DOI: 10.1016/j.oraloncology.2024.106866
Contributors: Robin Park; Jiannong Li; Robbert J.C. Slebos; Ritu Chaudhary; Maria I. Poole; Carina Ferraris; Joaquim Farinhas; Juan Hernandez-Prera; Kedar Kirtane; Jamie K. Teer et al.
Source: check_circle
Crossref

The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials

Journal of Hematology & Oncology
2021-12 | Journal article
DOI: 10.1186/s13045-021-01034-0
Part of ISSN: 1756-8722
Source: Self-asserted source
Robin Park

The Prognostic and Predictive Impact of BRAF Mutations in Deficient Mismatch Repair/Microsatellite Instability-High Colorectal Cancer: Systematic Review/Meta-Analysis

Future Oncology
2021-11 | Journal article
DOI: 10.2217/fon-2021-0552
Contributors: Robin Park; Laercio Lopes; Sunggon Lee; Ivy Riano; Anwaar Saeed
Source: check_circle
Crossref

Is Obesity a Risk Factor in Cancer Patients with COVID-19?

Future Oncology
2021-09 | Journal article
DOI: 10.2217/fon-2021-0676
Contributors: Robin Park; Elizabeth Wulff-Burchfield; Weijing Sun; Anup Kasi
Source: check_circle
Crossref

Current Landscape of Immunotherapy Trials in Locally Advanced and High-Risk Head and Neck Cancer

Immunotherapy
2021-08 | Journal article
DOI: 10.2217/imt-2021-0048
Contributors: Robin Park; Jong Chul Park
Source: check_circle
Crossref

Fulminant COVID-19-Associated Myocarditis in an Otherwise Healthy Female

Cureus
2021-01-16 | Journal article
DOI: 10.7759/cureus.12736
Part of ISSN: 2168-8184
Source: Self-asserted source
Robin Park

Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis

Clinical and Translational Oncology
2021-01-03 | Journal article
DOI: 10.1007/s12094-020-02397-5
Contributors: R. Park; L. Lopes; A. Saeed
Source: check_circle
Crossref

Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data

Acta Oncologica
2021-01-02 | Journal article
DOI: 10.1080/0284186X.2020.1837946
Contributors: Robin Park; Sul A. Lee; Seong Yoon Kim; Andreia Cristina de Melo; Anup Kasi
Source: check_circle
Crossref

Abstract PO-085: Sex bias in COVID-19-associated Illness severity and mortality in cancer patients: A systematic review and meta-analysis

Clinical Cancer Research
2020 | Journal article
DOI: 10.1158/1557-3265.COVID-19-PO-085
Part of ISSN: 1078-0432
Source: Self-asserted source
Robin Park

Exceptional response to neoadjuvant capecitabine and temozolomide in TSC2-mutant pancreatic neuroendocrine tumor

Current Problems in Cancer: Case Reports
2020-12 | Journal article
DOI: 10.1016/j.cpccr.2020.100037
Contributors: Robin Park; Deyali Chatterjee; Manik Amin; Nikolaos A. Trikalinos
Source: check_circle
Crossref

Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review

Journal of Pancreatic Cancer
2020-12-01 | Journal article
DOI: 10.1089/pancan.2020.0010
Part of ISSN: 2475-3246
Source: Self-asserted source
Robin Park

Outcomes Following Immunotherapy Re-Challenge After Immune-Related Adverse Event: Systematic Review and Meta-Analysis

Immunotherapy
2020-11 | Journal article
DOI: 10.2217/imt-2020-0103
Contributors: Robin Park; Laercio Lopes; Anwaar Saeed
Source: check_circle
Crossref

The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function

Cells
2020-10-14 | Journal article
DOI: 10.3390/cells9102294
Part of ISSN: 2073-4409
Source: Self-asserted source
Robin Park

Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis

EClinicalMedicine
2020-09 | Journal article
DOI: 10.1016/j.eclinm.2020.100519
Contributors: Robin Park; Anusha Chidharla; Kathan Mehta; Weijing Sun; Elizabeth Wulff-Burchfield; Anup Kasi
Source: check_circle
Crossref

Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-Augmented Clinical Trials

Current Colorectal Cancer Reports
2020-08 | Journal article
DOI: 10.1007/s11888-020-00456-1
Part of ISSN: 1556-3790
Part of ISSN: 1556-3804
Source: Self-asserted source
Robin Park

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study

Journal of Clinical Medicine
2020-08-19 | Journal article
DOI: 10.3390/jcm9092682
Part of ISSN: 2077-0383
Source: Self-asserted source
Robin Park

Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma

Vaccines
2020-08-08 | Journal article
DOI: 10.3390/vaccines8030447
Part of ISSN: 2076-393X
Source: Self-asserted source
Robin Park
grade
Preferred source (of 2)‎

Cabozantinib (cabo) combined with durvalumab (durva) in gastroesophageal (GE) cancer and other gastrointestinal (GI) malignancies: Preliminary phase Ib CAMILLA study results.

Journal of Clinical Oncology
2020-05-20 | Journal article
DOI: 10.1200/jco.2020.38.15_suppl.4563
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Robin Park

Checkpoint inhibitor-associated immune-related adverse events as harbinger of favorable clinical outcome: Systematic review and meta-analysis.

Journal of Clinical Oncology
2020-05-20 | Journal article
DOI: 10.1200/jco.2020.38.15_suppl.e15129
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Robin Park

Treatment-related adverse events of combination immune checkpoint inhibitors: Systematic review and meta-analysis.

Journal of Clinical Oncology
2020-05-20 | Journal article
DOI: 10.1200/jco.2020.38.15_suppl.e15060
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Robin Park

Complete Resolution of a Large, Locally-advanced Cutaneous Squamous Cell Carcinoma with the Immune-modulating PD-1 Inhibitor Pembrolizumab

Cureus
2020-05-12 | Journal article
DOI: 10.7759/cureus.8072
Part of ISSN: 2168-8184
Source: Self-asserted source
Robin Park

Cutaneous paraneoplastic syndrome associated with anal squamous cell carcinoma: a rare presentation of an uncommon cancer

Current Oncology
2020-04-20 | Journal article
DOI: 10.3747/co.27.6557
Part of ISSN: 1718-7729
Part of ISSN: 1198-0052
Source: Self-asserted source
Robin Park

Association Between the Functional miR-146a SNP rs2910164 and Risk of Digestive System Cancer: Updated Meta-analysis

Anticancer Research
2020-03 | Journal article
DOI: 10.21873/anticanres.14094
Part of ISSN: 0250-7005
Part of ISSN: 1791-7530
Source: Self-asserted source
Robin Park

Treatment-Related Adverse Events of Combination Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis

Frontiers in Oncology
2020-03-17 | Journal article
DOI: 10.3389/fonc.2020.00258
Part of ISSN: 2234-943X
Source: Self-asserted source
Robin Park

Pathologically Complete Response after Triple Therapy in Locally Advanced Esophageal Cancer in a Hereditary Hemorrhagic Telangiectasia Patient

Case Reports in Oncology
2020-02-18 | Journal article
DOI: 10.1159/000505832
Part of ISSN: 1662-6575
Source: Self-asserted source
Robin Park

Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma

Clinical Colorectal Cancer
2019-06 | Journal article
DOI: 10.1016/j.clcc.2019.02.005
Part of ISSN: 1533-0028
Source: Self-asserted source
Robin Park

Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer

Anticancer Research
2018-10 | Journal article
DOI: 10.21873/anticanres.12891
Part of ISSN: 0250-7005
Part of ISSN: 1791-7530
Source: Self-asserted source
Robin Park

The Role of Bile Acid Receptors in Chronic Inflammatory Diseases

Journal of Rheumatic Diseases
2017 | Journal article
DOI: 10.4078/jrd.2017.24.5.253
Part of ISSN: 2093-940X
Part of ISSN: 2233-4718
Source: Self-asserted source
Robin Park

Gene Expression Profile in Patients with Axial Spondyloarthritis: Meta-analysis of Publicly Accessible Microarray Datasets

Journal of Rheumatic Diseases
2016 | Journal article
DOI: 10.4078/jrd.2016.23.6.363
Part of ISSN: 2093-940X
Part of ISSN: 2233-4718
Source: Self-asserted source
Robin Park

Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis

Autoimmunity
2016-10-02 | Journal article
DOI: 10.3109/08916934.2016.1171854
Part of ISSN: 0891-6934
Part of ISSN: 1607-842X
Source: Self-asserted source
Robin Park

Unique gene expression profile in osteoarthritis synovium compared with cartilage: analysis of publicly accessible microarray datasets

Rheumatology International
2016-06 | Journal article
DOI: 10.1007/s00296-016-3451-1
Part of ISSN: 0172-8172
Part of ISSN: 1437-160X
Source: Self-asserted source
Robin Park

Calcium channels: the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis

Inflammation Research
2016-05 | Journal article
DOI: 10.1007/s00011-016-0920-7
Part of ISSN: 1023-3830
Part of ISSN: 1420-908X
Source: Self-asserted source
Robin Park

Cyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice

PLOS ONE
2015-09-16 | Journal article
DOI: 10.1371/journal.pone.0138222
Part of ISSN: 1932-6203
Source: Self-asserted source
Robin Park

Peer review (1 review for 1 publication/grant)

Review activity for PloS one. (1)
How many people are using ORCID?